☆
Watchlist
Log in
Sign-up
New Zealand Coastal Seafoods Ltd (nzs) Logo

New Zealand Coastal Seafoods Ltd (NZS)

___:___ · Consumer Defensive
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

NZS Chart

Snapshot

NZS's Principal Activity is the produce nutraceutical, seafood products and premium marine ingredients.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -66.32%
vs ASX 200 (1yr) -56.12%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,271 of 2,427
Sector Rank 94 of 96

Key Fundamentals

Shares Issued
Sector Consumer Defensive
Similar Companies EVE / ERG / CSF
EPS -$0.004
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

NZS is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

New Zealand Coastal Seafoods (NZS, formerly XTV Networks Ltd) is a New Zealand based, ASX listed, secondary producer of nutraceutical, seafood products and premium marine ingredients. The Company recently acquired Kiwi Dreams International Limited (KDI), a developer of innovative nutraceutical products and services including ingredient supply, quality and validation, as well as formulation and development.

Incorporation Details

Incorporated Uramet Minerals Limited was incorporated in March 2007 in Western Australia, Australia. Code changed to Intercept Minerals Ltd (IZM) on 15/07/2011

Corporate Details

Head Office Nedlands WA 6009
Website www.nzcs.co
Registry Automic Group
Auditor Crowe Perth
Date Listed 19 Jun 2007

Upcoming Calendar (Forecasted)

Date Event
30/08/2022 Report (Prelim)
30/08/2022 Report (Annual)
26/10/2022 Report (Annual)
27/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Nathan Maxwell-McGinn Non-Executive Director Feb 2021

Mr Nathan Maxwell-McGinn

Non-Executive Director

Mr McGinn is a co-founder, shareholder and marketing manager of JSJ Seafood Pty Ltd ("JSJ Seafood"), a company which exports over $50 million annually of Australian and International seafood to Asia, under the "Three Capes" brand. JSJ Seafood was formed in 2016 and is currently the largest exporter of rock lobster from Tasmania, with an established trading and marketing division "Three Capes", which utilises an customer network to market, promote and drive sales for selected clients globally. JSJ Seafood has experienced continued high growth since launching in 2016, demonstrating Mr Maxwell-McGinn's ability to achieve financial growth and strategic milestones, driven by his marketing experience and international contacts within the seafood sector. He holds experience in international trade, marketing, business and brand development, and has assisted companies in Europe, South America and Africa develop new markets in Asia. Former roles include Business Development Manager of Kailis Bros / Legend Group Holdings, with Mr Maxwell-McGinn joining the company after the takeover of Kailis Bros by Legend Group Holdings (Hong Kong). Under this role, he managed the export team and developed key relationships with partners globally, launched the Kailis Brother export brand in Asia, and established retail presence in HK. He is the chair of the Seafood Trade Advisory Group, a group that has developed key Government relationships in Canberra to provide advice on Free Trade Agreements and Trade and Market access issues.

Mr Evan Hayes Non-Executive Director Jan 2021

Mr Evan Hayes

Non-Executive Director

Mr Hayes is a Executive and Non-Executive Director with broad strategic experience across a portfolio of board positions, and substantial experience in the health industry including senior product development and operations roles with Factors, Blackmores and BioCeuticals. He is currently Asia Pacific Managing Director of Factors Group, Canada's largest natural health company and a Director of MGC Pharma, an ASX listed biotech & cannabis company. As a scientist, specialising in medicines, both natural and biotech, he has the unique capability of leveraging deep technical skills to develop real commercial outcomes. Mr Hayes is particularly specialised in the management, set up and scaling of start-up organisations, where there is a fast-moving environment balancing a need for strategy, scale, business development, overseas expansion, risk and compliance. Mr Hayes holds over 20 years experience in leading organisations in Australia and overseas, and has worked in Europe, the USA and in Australia. He has a practical understanding of both the FDA and the TGA with a detailed knowledge of strategic, financial, human resource and compliance issues. He also holds senior executive experience in the natural medicine sector, as well as extensive consulting experience across portfolios including procurement, product development and health economics for leading Australian organisations through his consulting organisations, Relae and FIT Milestones. Evan is passionate about natural products, experimental and clinical research, has initiated and published research in diverse areas such as immunoassay development, probiotic functionality, and Vitamin D insufficiency and is an author of multiple patents including one world patent.

Mr Andrew Peti Chief Executive Officer Mar 2020
Mr Cataldo (Aldo) Miccio Executive Director Jul 2019

Mr Cataldo (Aldo) Miccio

Executive Director

Mr Miccio was the mayor of Nelson, New Zealand, and prior to that served as a Councillor of Nelson, beginning in 2007. In 2010, Mr Miccio successfully sold Bissi Ltd, an apparel company he had started in 1998. He is also former Managing Director of KELA and is the current chairman of Medical Kiwi Ltd.

Mr Winton William Willesee Non-Executive Chairman,Non-Executive Director Jul 2016

Mr Winton William Willesee

Non-Executive Chairman,Non-Executive Director

Mr Willesee is an experienced company director and secretary with over 20 years experience in various roles within the Australian capital markets. Mr Willesee has considerable experience with ASX listed and other companies over a broad range of industries having been involved with many successful ventures from early stage through to large capital development projects. He has a expertise in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance

Ms Erlyn Dale Company Secretary,Non-Executive Director Jul 2016

Ms Erlyn Dale

Company Secretary,Non-Executive Director

Ms Dale is an experienced corporate professional with a broad range of corporate governance and capital markets experience, having been involved with several public company listings, merger and acquisition transactions and capital raisings for ASX-listed companies across a diverse range of industries. Miss Dale began her career in corporate recovery and restructuring at Ferrier Hodgson and is now the Managing Director of corporate services firm, Azalea Consulting, which provides outsourced company secretarial, accounting and administration services to a portfolio of ASX-listed companies.

Robert Wells Chief Financial Officer N/A
Alexander Zu Ming Li Director of NZCS Operations Limited N/A
Peter Win General Manager Business Development N/A

Director Transactions

NZS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
09/12/21 Nathan Maxwell-McGinn Buy +5,500,000 $0.009 $49,500 As advised by the company
09/12/21 Evan Hayes Buy +5,500,000 $0.009 $49,500 As advised by the company
29/06/21 Winton Willesee Buy +225,715 $0.012 $2,708 On-market trade
21/06/21 Winton Willesee Buy +350,000 $0.012 $4,200 On-market trade
22/12/20 Cataldo (Aldo) Miccio Buy +20,000 $0.019 $380 On-market trade
04/12/20 Winton Willesee Issued 13,500,000 $0.024 $324,000 Issue of securities
04/12/20 Erlyn Dale Issued 9,000,000 $0.024 $216,000 Issue of securities
04/12/20 Cataldo (Aldo) Miccio Issued 9,000,000 $0.024 $216,000 Issue of securities
06/10/20 Cataldo (Aldo) Miccio Buy +21,305 $0.043 $916 On-market trade
02/10/20 Winton Willesee Issued 714,286 $0.042 $30,000 Participation in share purchase plan
30/07/20 Cataldo (Aldo) Miccio Buy +35,000 $0.027 $945 On-market trade
29/06/20 Winton Willesee Issued 100,834 $0.01 $1,008 Rights issue
29/06/20 Winton Willesee Issued 302,500 $0.01 $3,025 Rights issue
02/01/20 Cataldo (Aldo) Miccio Buy +55,205 $0.015 $828 On-market trade
02/01/20 Cataldo (Aldo) Miccio Buy +55,205 $0.015 $828 On-market trade
25/07/19 Erlyn Dale Transfer 8,000,000 $0.008 $64,000 Off-market transfer
25/07/19 Winton Willesee Cancelled 75,000,000 $0.008 $600,000 Ceased association with an entity
25/07/19 Winton Willesee Cancelled 60,000,000 $0.008 $480,000 Ceased association with an entity

Director Interests

The current holdings of NZS directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Nathan Maxwell-McGinn 09/12/2021 0 N/A 5,500,000 N/A
Evan Hayes 09/12/2021 0 N/A 5,500,000 N/A
Cataldo (Aldo) Miccio 30/06/2021 52,918,240 N/A 13,566,000 N/A
Erlyn Dale 30/06/2021 N/A N/A 8,000,000 N/A
Winton Willesee 30/06/2021 N/A 2,500,000 100,834 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 16, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Mr Cataldo Miccio 52,918,240 6.40%
Alexander Trading Corporation Limited 52,786,730 6.38%
Mr Peter James Win 52,786,730 6.38%
Bergen Global Opportunity Fund Lp 49,500,000 5.99%
Sandhurst Trustees Ltd <Cyan C3G Fund A/C> 36,581,806 4.42%
Custodial Services Limited <Beneficiaries Holding A/C> 21,583,560 2.61%
Mr Waldemar Wawrzyniuk & Ms Lia Wawrzyniuk <L & W Super Fund A/C> 15,000,000 1.81%
Citicorp Nominees Pty Limited 13,928,250 1.68%
Mr Hien Quang Trinh <Trivest Capital A/C> 11,886,218 1.44%
Ac Young Pty Ltd <Ac Young A/C> 10,000,000 1.21%
Mr Richard Fryers 8,409,747 1.02%
Mr Chang Yuan Chen 8,334,747 1.01%
Dr William Gladstone Burn 7,000,000 0.85%
Proll Investments Pty Ltd <Proll Family A/C> 7,000,000 0.85%
Surf Coast Capital Pty Ltd <Minnie P/F A/C> 5,500,000 0.67%
BNP Paribas Nominees Pty Ltd <IB Au Noms Retailclient DRP> 5,315,510 0.64%
Mr Simon James Costello 5,016,801 0.61%
Mr Sachin Goyal 5,000,000 0.60%
Mr Michael John Bereza 5,000,000 0.60%
Mr Andrew John Sneddon & Mrs Judith Anne Sneddon <A J Sneddon Family A/C> 4,500,000 0.54%
Mr Peter Buchanan Stevenson 4,185,057 0.51%
Est Mr Robert Steel Renton 4,062,001 0.49%
Mr Christopher Lawrence Wilson 4,000,000 0.48%
Mr Michael James Lowe & Mrs Maria-Luisa Lowe 4,000,000 0.48%
Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 812 387 206 1,256 805 3,466

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Peter James Win 16/08/2021 54,505,080 6.59
Cataldo Miccio 16/08/2021 52,786,730 6.38
Alexander Trading Corporation Limited 16/08/2021 52,786,730 6.38
Cyan Investment Management 16/08/2021 36,581,806 5.03

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
19-08-21 Bergen Global Opportunity Fund, LP 139,688,864 19.2 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.013 30 June
2020 $0.009 30 June
NZS Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.